Lambek C - Search Results

1

A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.

Wisniewski D, Strife A, Wojciechowicz D, Lambek C, Clarkson B. Wisniewski D, et al. Among authors: lambek c. Leukemia. 1994 Apr;8(4):688-93. Leukemia. 1994. PMID: 8152267

2

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.

Clarkson B, Strife A, Wisniewski D, Lambek CL, Liu C. Clarkson B, et al. Among authors: lambek cl. Leukemia. 2003 Jul;17(7):1211-62. doi: 10.1038/sj.leu.2402912. Leukemia. 2003. PMID: 12835715 Review.

3

Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.

Lemoli RM, Gulati SC, Strife A, Lambek C, Perez A, Clarkson BD. Lemoli RM, et al. Among authors: lambek c. Leukemia. 1991 May;5(5):386-91. Leukemia. 1991. PMID: 1709711

4

Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.

Wisniewski D, Strife A, Arlin Z, Knowles R, Lambek C, Gulati S, McHendry B, McKenzie S, Clarkson B. Wisniewski D, et al. Among authors: lambek c. Leukemia. 1989 Jun;3(6):446-52. Leukemia. 1989. PMID: 2657231

5

Discordant maturation as the primary biological defect in chronic myelogenous leukemia.

Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD. Strife A, et al. Among authors: lambek c. Cancer Res. 1988 Feb 15;48(4):1035-41. Cancer Res. 1988. PMID: 3422181

6

Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.

Strife A, Perez A, Lambek C, Wisniewski D, Bruno S, Darzynkiewicz Z, Clarkson B. Strife A, et al. Among authors: lambek c. Cancer Res. 1993 Jan 15;53(2):401-9. Cancer Res. 1993. PMID: 7678076

7

Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand.

Strife A, Perez A, Lambek C, Wisniewski D, Bruno S, Darzynkiewicz Z, Clarkson B. Strife A, et al. Among authors: lambek c. Leuk Res. 1993 Sep;17(9):799-807. doi: 10.1016/0145-2126(93)90115-2. Leuk Res. 1993. PMID: 7690436 Free article.

8

Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML).

Clarkson B, Strife A, Perez A, Lambek C, Wisniewski D. Clarkson B, et al. Among authors: lambek c. Leuk Lymphoma. 1993;11 Suppl 2:81-100. doi: 10.3109/10428199309064267. Leuk Lymphoma. 1993. PMID: 8124237

9

New understanding of the pathogenesis of CML: a prototype of early neoplasia.

Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N. Clarkson BD, et al. Among authors: lambek c. Leukemia. 1997 Sep;11(9):1404-28. doi: 10.1038/sj.leu.2400751. Leukemia. 1997. PMID: 9305592 Review.

10

Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL).

Berman E, Jhanwar S, McBride M, Strife A, Wisniewski D, Lambek C, Clarkson B. Berman E, et al. Among authors: lambek c. Leuk Res. 2000 Apr;24(4):289-97. doi: 10.1016/s0145-2126(99)00179-4. Leuk Res. 2000. PMID: 10713326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters